First-year sales of GSK's Alli 'underwhelming,' analyst says
Stephen McGuire
June 12 2008
Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.